Search Results

There are 109772 results for: content related to: The incidence and impact of thrombocytopenia in myelodysplastic syndromes

  1. You have free access to this content
    Myelodysplastic syndromes: biology and treatment

    Journal of Internal Medicine

    Volume 265, Issue 3, March 2009, Pages: 307–328, M. Jädersten and E. Hellström-Lindberg

    Version of Record online : 17 DEC 2008, DOI: 10.1111/j.1365-2796.2008.02052.x

  2. You have free access to this content
    Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management

    American Journal of Hematology

    Volume 90, Issue 9, September 2015, Pages: 831–841, Guillermo Garcia-Manero

    Version of Record online : 21 AUG 2015, DOI: 10.1002/ajh.24102

  3. The Myelodysplastic Syndrome

    Standard Article

    Holland-Frei Cancer Medicine

    Lewis R. Silverman

    Published Online : 26 FEB 2017, DOI: 10.1002/9781119000822.hfcm114

  4. You have free access to this content
    Advances in the prognostication and management of advanced MDS in children

    British Journal of Haematology

    Volume 154, Issue 2, July 2011, Pages: 185–195, Henrik Hasle and Charlotte M. Niemeyer

    Version of Record online : 9 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08724.x

  5. You have free access to this content
    Guidelines for the diagnosis and management of adult myelodysplastic syndromes

    British Journal of Haematology

    Volume 164, Issue 4, February 2014, Pages: 503–525, Sally B. Killick, Chris Carter, Dominic Culligan, Christopher Dalley, Emma Das-Gupta, Mark Drummond, Helen Enright, Gail L. Jones, Jonathan Kell, Juliet Mills, Ghulam Mufti, Jane Parker, Kavita Raj, Alexander Sternberg, Paresh Vyas, David Bowen and British Committee for Standards in Haematology

    Version of Record online : 23 DEC 2013, DOI: 10.1111/bjh.12694

    Corrected by:

    Corrigenda: Corrigenda

    Vol. 166, Issue 4, 629, Version of Record online: 25 JUL 2014

  6. The burden of autoimmunity in myelodysplastic syndromes

    Hematological Oncology

    Claudio Fozza

    Version of Record online : 27 APR 2017, DOI: 10.1002/hon.2423

  7. You have free access to this content
    The myelodysplastic syndromes: the era of understanding

    European Journal of Haematology

    Volume 94, Issue 5, May 2015, Pages: 379–390, Stef Meers

    Version of Record online : 1 OCT 2014, DOI: 10.1111/ejh.12443

  8. You have free access to this content
    Myelodysplastic syndromes: Contemporary review and how we treat

    American Journal of Hematology

    Volume 91, Issue 1, January 2016, Pages: 76–89, Naseema Gangat, Mrinal M. Patnaik and Ayalew Tefferi

    Version of Record online : 23 DEC 2015, DOI: 10.1002/ajh.24253

  9. You have free access to this content
    Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

    American Journal of Hematology

    Volume 89, Issue 1, January 2014, Pages: 97–108, Guillermo Garcia-Manero

    Version of Record online : 24 JAN 2014, DOI: 10.1002/ajh.23642

  10. You have free access to this content
    DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMES: FACT OR FICTION?

    British Journal of Haematology

    Volume 102, Issue 5, September 1998, Pages: 1124–1138, Valeria Santini and Pierluigi Rossi Ferrini

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1365-2141.1998.00881.x

  11. You have free access to this content
    Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management

    American Journal of Hematology

    Volume 87, Issue 7, July 2012, Pages: 692–701, Guillermo Garcia-Manero

    Version of Record online : 14 JUN 2012, DOI: 10.1002/ajh.23264

  12. You have free access to this content
    Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes

    British Journal of Haematology

    Volume 162, Issue 5, September 2013, Pages: 587–605, Austin G. Kulasekararaj, Azim M. Mohamedali and Ghulam J. Mufti

    Version of Record online : 19 JUL 2013, DOI: 10.1111/bjh.12435

  13. You have free access to this content
    The molecular pathogenesis of the myelodysplastic syndromes

    European Journal of Haematology

    Volume 95, Issue 1, July 2015, Pages: 3–15, Andrea Pellagatti and Jacqueline Boultwood

    Version of Record online : 20 FEB 2015, DOI: 10.1111/ejh.12515

  14. You have free access to this content
    Novel therapies for myelodysplastic syndromes

    Cancer

    Volume 101, Issue 2, 15 July 2004, Pages: 226–241, Stefan Faderl and Hagop M. Kantarjian

    Version of Record online : 14 JUN 2004, DOI: 10.1002/cncr.20381

  15. You have free access to this content
    Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy

    British Journal of Haematology

    Volume 153, Issue 5, June 2011, Pages: 568–581, Shikhar Aggarwal, Arjan A. van de Loosdrecht, Canan Alhan, Gert J. Ossenkoppele, Theresia M. Westers and Hetty J. Bontkes

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1365-2141.2011.08683.x

  16. You have free access to this content
    Current therapeutic approaches for patients with myelodysplastic syndromes

    British Journal of Haematology

    Volume 150, Issue 2, July 2010, Pages: 131–143, Peter L. Greenberg

    Version of Record online : 9 MAY 2010, DOI: 10.1111/j.1365-2141.2010.08226.x

  17. You have free access to this content
    Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management

    American Journal of Hematology

    Volume 86, Issue 6, June 2011, Pages: 490–498, Guillermo Garcia-Manero

    Version of Record online : 18 MAY 2011, DOI: 10.1002/ajh.22047

  18. You have free access to this content
    Deferasirox for managing iron overload in people with myelodysplastic syndrome

    Intervention Review

    The Cochrane Library

    Joerg J Meerpohl, Lisa K Schell, Gerta Rücker, Nigel Fleeman, Edith Motschall, Charlotte M Niemeyer and Dirk Bassler

    Published Online : 28 OCT 2014, DOI: 10.1002/14651858.CD007461.pub3

  19. STEM CELL TRANSPLANTATIONFOR LEUKEMIAS FOLLOWING MYELODYSPLASTIC SYNDROMESOR SECONDARYTO CYTOTOXIC THERAPY

    Reviews in Clinical and Experimental Hematology

    Volume 6, Issue 1, March 2002, Pages: 72–85, Theo de Witte, Margriet Oosterveld, Bart Span, Petra Muus and Anton Schattenberg

    Version of Record online : 26 APR 2002, DOI: 10.1046/j.1468-0734.2002.00057.x

  20. Myelodysplastic syndromes: What do hospitalists need to know?

    Journal of Hospital Medicine

    Volume 8, Issue 6, June 2013, Pages: 351–357, Amer M. Zeidan, Bishoy Faltas, B. Douglas Smith and Steven Gore

    Version of Record online : 11 MAY 2013, DOI: 10.1002/jhm.2049